New drug targets identified for retinitis pigmentosa therapies

An international team of researchers has identified new drug targets for therapies that could benefit patients with different forms of retinitis pigmentosa and other inherited retinal diseases.

The Biggest Psychedelic News This Week – October 23rd | Psychedelic Spotlight

RESEARCH More Research Investigating Psychedelics For Cancer Patients Its a collaborative effort to substantiate claims. New York University (NYU) School of Medicine’s Center for Psychedelic

October 27, 2023

Risk Adjusted Net Present Value: What is the current valuation of Shionogi’s Resiniferatoxin

The revenue for Resiniferatoxin is expected to reach an annual total of $34 mn by 2035 globally based off GlobalData’s Expiry Model. The drug’s revenue

July 31, 2023

House Staff Unionization Has Come in Waves

Lately, resident physicians and fellows have been unionizing in droves. However, it’s far from a new phenomenon. Amid a resurgent landscape, “it is important to

September 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.